All rights reserved. © 2019 LeadingBiotech

DOWNLOAD THE BOSTON CEO BROCHURE NOW 

SUBMIT

East/West CEO is a networking forum for CEOs and decision makers in the life sciences. Participants gain insights from off-the-record discussion panels, keynotes, and fireside chats featuring CEOs and thought leaders from several of the world’s leading biopharmaceutical companies. Healthcare investors and leading researchers also participate. 

George Church

Professor of Genetics

Harvard Medical School

2019 Speakers Include:

Bob Coughlin

President & CEO

Mass Bio

Luba Greenwood

Strategic BD & Corp. Ventures

Virily (Google Life Sciences)

STAY AT THE FOREFRONT OF BIOTECH INNOVATION BY TAPPING INTO THE RICHEST POOL OF FINANCE, EXPERIENCE, AND TALENT

May 28-29, 2019

Four Seasons Hotel

Boston, MA

JAN. 6-7, 2018

Jeff Jonas

CEO

Sage Therapeutics

Laurie Glimcher

President & CEO

Dana Farber Cancer Institute

Jeremy Levin

Chairman & CEO

Ovid Therapeutics

#BOSTONCEO

2019 Recently Added Speakers

Laurent Audoly, President and Chief Executive Office, Kymera Therapeutics
Bruce Booth, Ph.D., Partner, Atlas Venture 
Chris Coburn, Chief Innovation Officer, Partners HealthCare; President Partners HealthCare International
Grace Colon, Ph.D., CEO and President, InCarda Therapeutics
Christopher de Souza, Director,  Broadview Ventures
Thomas de Vlaam, CEO, Amylon Therapeutics
Allene Diaz, Senior Vice President, Global Commercial Development and Program Strategy, TESARO, Inc 
Scott Elmer, Director, Office of Technology Licensing, St Jude Children’s Research Hospital 
Mariya Filipova, VP Innovation,  Anthem
Halley Gilbert, Senior Vice President & Chief Legal Officer, Ironwood Pharmaceuticals
John Glasspool, CEO, Anthos Therapeutics
Andrew Hobbs, Managing Director, Huron life Sciences
Thomas Hughes, Chief Executive Officer, Navitor Pharmaceuticals
Cigall Kadoch, Founder, Foghorn Therapeutics; Assistant Professor, Department of Pediatric Oncology Dana-Farber Cancer Institute and Harvard Medical School Institute Member and Epigenomics Program Co-Director, Broad Institute
Julie Kampf, CEO, Chief Possibilities Officer & Board Talent Champion, JBK Associates
Sarah Larson, Partner/CHRO, Third Rock Ventures
Harry L. Leider, M.D., MBA, FACPE, Chief Medical Officer and Executive Vice President, Gelesis
Lewis Levy, M.D., FACP, Chief Medical Officer, Teladoc Health
Manuel Litchman, M.D., President & CEO Mustang Bio, Inc.
Ewelina K. Mamcarz, Assistant Member Department of Bone Marrow Transplantation & Cellular Therapy, St Jude Children’s Research Hospital
Josh Mandel-Brehm, CEO, CAMP4 Therapeutics; Entrepreneur Partner, Polaris Partners
Jodie Morrison, Chief Executive Officer, Cadent Therapeutics
Deborah Palestrant, Ph.D., Partner, Head of 4:59, 5AM Ventures 
Robert Perez, Operating Partner, General Atlantic
Andy Plump, M.D., Ph.D., President, R&D, Takeda Pharmaceutical Co., Ltd.
Chandra Ramanathan, Head East Coast Innovation Center, Bayer
Rich Rieger, Managing Director, Huron life Sciences
Rachel Sha, Head, Digital Business Development & Licensing Global Business Development & Licensing, Sanafoi
Michael Sherman, M.D., Senior VP and CMO, Harvard Pilgrim Health Care
Paula Soteropoulos, CEO, Akcea Therapeutics
Mary Thistle, Chief of Staff, Bill & Melinda Gates Medical Research Institute
Ailis Tweed-Kent, CEO, Cocoon Biotech 
Arthur Tzianabos, Ph.D., President and Chief Executive Office, Homology Medicines, Inc.
Sue Washer, President & CEO, Applied Genetic Technologies Corporation (AGTC)
John Westwood, Managing Partner, Huron Life Sciences
Cissy Young, Ph.D., Executive Director, Russell Seynolds Associates

Fix the following errors:
Hide